Skip to main content
Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.310
-0.010 (-0.76%)
At close: Feb 27, 2026, 4:00 PM EST
1.310
0.00 (-0.01%)
After-hours: Feb 27, 2026, 7:52 PM EST

Akebia Therapeutics Revenue

In the year 2025, Akebia Therapeutics had annual revenue of $236.20M with 47.46% growth. Akebia Therapeutics had revenue of $57.62M in the quarter ending December 31, 2025, with 23.92% growth.

Revenue (ttm)
$236.20M
Revenue Growth
+47.46%
P/S Ratio
1.49
Revenue / Employee
$1,304,950
Employees
181
Market Cap
350.92M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025236.20M76.02M47.46%
Dec 31, 2024160.18M-34.44M-17.70%
Dec 31, 2023194.62M-97.86M-33.46%
Dec 31, 2022292.48M80.83M38.19%
Dec 31, 2021211.65M-82.99M-28.17%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emergent BioSolutions 742.90M
Organogenesis Holdings 564.17M
Evolus 285.82M
Aurora Cannabis 272.13M
Canopy Growth 203.04M
Kamada 174.79M
SIGA Technologies 172.25M
Lifecore Biomedical 128.87M
Revenue Rankings

AKBA News

More News